Evidence-led vulnerability intelligence · 2026-10-20 13:46 IST

CVE-2026-112177

A flaw was found in Ghostscript as shipped with Red Hat Enterprise Linux 8. The correction for CVE-2019-14869 was omitted during the rebase from version 9.25 to 9.27, leaving privileged .forceput operations in the .charkeys procedure insufficiently protected. Processing a specially crafted PostScript file may allow an attacker to bypass -dSAFER restrictions and access files outside the permitted paths or execute commands with the permissions of the Ghostscript process.

HIGH · 7.3Linux

Executive briefing

The source record describes: A flaw was found in Ghostscript as shipped with Red Hat Enterprise Linux 8. The correction for CVE-2019-14869 was omitted during the rebase from version 9.25 to 9.27, leaving privileged .forceput operations in the .charkeys procedure insufficiently protected. Processing a specially crafted PostScript file may allow an attacker to bypass -dSAFER restrictions and access files outside the permitted paths or execute commands with the permissions of the Ghostscript process. The practical risk depends on whether an affected product/version is present, reachable and configured in an exploitable way. Review the affected-product evidence and linked vendor advisories before assigning exposure status.

Assessment: Potential exposure only — validate the installed product, exact version, configuration and vendor applicability before treating an asset as confirmed vulnerable.

Evidence confidence: Limited Evidence-derived, not an exploitability verdict

Severity & attack characteristics

7.3 / 10 · 3.1

CVSS vector:
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

Attack vectorN
Attack complexityL
Privileges requiredN
User interactionN
ScopeU
Confidentiality impactL
Integrity impactL
Availability impactL

Technical explanation & impact

The technical mechanism is not expanded beyond the source description unless a referenced advisory supplies additional evidence. Read the linked vendor/CERT advisories for root-cause detail.

Potential impact must be interpreted from the published CVSS impact metrics and the affected component. A CVSS impact score is not proof that a particular asset is exploitable.

Weakness classification

CWE-648

Affected products and versions

NVD has not supplied machine-readable vulnerable CPE product/version entries for this CVE. This is an information gap, not proof that no products are affected. Check the vendor advisory references below.

Remediation & validation

  1. Identify exposure by comparing the affected product and version ranges with your asset inventory, SBOM and externally exposed services.
  2. Review the linked vendor security advisory or patch notes. Upgrade to a vendor-confirmed fixed release; do not infer a fixed version from the CVE description.
  3. Until patched, consider restricting network access or disabling the affected feature where operationally safe. These are temporary controls, not a substitute for a vendor fix.
  4. Validate the remediation with a version check and vulnerability rescan, then retain change evidence.

No fixed version is displayed unless it is explicitly established by a vendor advisory. Follow the vendor's release notes for exact product and branch applicability.

Vendor advisories, patches & exploit references

Information gaps & confidence notes

These gaps indicate missing source data. CVE Watch does not fill them with guessed product, exploit or patch details.

Last enrichment: 2026-11-04T22:31:47+00:00 · Source last modified: 2026-11-04T22:17:48.170

Open NVD record ← Back to CVE Watch

Threat intelligence, made actionable · CVE data sourced from the NVD